Baudax Bio BXRX

$ 0.19 0.59%

Quarterly report 2023-Q3
added 11-20-2023

Baudax Bio Income Statement 2011-2024 | BXRX

Annual Income Statement Baudax Bio

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	779 K	356 K	12.4 M	80.3 M	-	-	-	-	-	-	-	-
Shares	332 K	54.7 K	9.35 M	9.35 M	-	-	-	-	-	-	-	-
Historical Prices	2.35	6.51	46.5	293	-	-	-	-	-	-	-	-
Net Income	-58.8 M	-19.8 M	-76.1 M	-32.6 M	-73.7 M	-61.1 M	-	-	-	-	-	-
Revenue	1.27 M	1.08 M	493 K	-	-	-	-	-	-	-	-	-
Cost of Revenue	7.01 M	2.44 M	1.73 M	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-1.24 M	-	-	-	-	-	-	-	-	-
Operating Income	-56.8 M	-19 M	-74.8 M	-32.5 M	-73.5 M	-	-	-	-	-	-	-
Interest Expense	-	-	1.36 M	-	-	-	-	-	-	-	-	-
EBITDA	-56.6 M	-18.8 M	-53.7 M	-46.6 M	-56.1 M	-35.4 M	-	-	-	-	-	-
Operating Expenses	-	-	54.6 M	47.1 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	24.1 M	45.3 M	43.3 M	27 M	29.5 M	19.6 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Baudax Bio

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	7.99 M	4.89 M	2.32 M	1.62 M	296 K	180 K	101 K	2.81 M	2.41 M	2.14 M	1.79 M	1.39 M	18.4 M	17.7 M	10 M	9.35 M	9.35 M	9.35 M	9.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-1.93 M	-7.38 M	11.4 M	-	-29.2 M	-7.53 M	-12.8 M	-	-17 M	-15.3 M	-16.9 M	-	11.7 M	-30.4 M	-40.3 M	-	-10.3 M	-10.6 M	-4.34 M	-	-19.1 M	-20.4 M	-17.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	30 K	14 K	-	238 K	300 K	422 K	-	281 K	201 K	198 K	-	68 K	349 K	516 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	43 K	104 K	405 K	-	1.21 M	361 K	648 K	-	462 K	586 K	821 K	-	540 K	650 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-1.78 M	-7.04 M	-4.69 M	-	-3.58 M	-3.78 M	-7.62 M	-	-16.4 M	-16.3 M	-16.3 M	-	-12.3 M	-30.2 M	-40.3 M	-	-10.3 M	-10.6 M	-4.3 M	-	-19.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-1.64 M	-7.04 M	-4.68 M	-	-3.57 M	-3.76 M	-7.61 M	-	-16.3 M	-16.3 M	-16.2 M	-	-12.2 M	-30.1 M	-40.2 M	-	-10.2 M	-10.4 M	-4.18 M	-	-18.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	40.3 M	-	10.3 M	-	4.3 M	-	19.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.64 M	2.25 M	1.77 M	-	2.95 M	2.9 M	6.93 M	-	11.1 M	10.6 M	12.1 M	-	13.8 M	11.2 M	8.05 M	-	4.52 M	7.45 M	9.84 M	-	5.11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency